{"id":28348,"date":"2023-03-31T07:59:55","date_gmt":"2023-03-31T07:59:55","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/be-fr\/?page_id=28348"},"modified":"2023-05-12T10:08:29","modified_gmt":"2023-05-12T10:08:29","slug":"miguel-barrero","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero","title":{"rendered":"MIGUEL BARRERO"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"28348\" class=\"elementor elementor-28348\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7f808905 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7f808905\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;f02b98c&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-3d70389b\" data-id=\"3d70389b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-75ad8cba elementor-widget elementor-widget-image\" data-id=\"75ad8cba\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"716\" height=\"700\" src=\"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg\" class=\"attachment-large size-large wp-image-28338\" alt=\"\" srcset=\"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg 716w, https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero-300x293.jpg 300w, https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero-600x587.jpg 600w\" sizes=\"(max-width: 716px) 100vw, 716px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-74b8bffa elementor-section-content-top elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"74b8bffa\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;5f899ce&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-60646bf2\" data-id=\"60646bf2\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-15700adb elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"15700adb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"fab fa-linkedin-in\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-15490b\" data-id=\"15490b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1cc52f3 elementor-widget elementor-widget-heading\" data-id=\"1cc52f3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\"><a href=\"https:\/\/www.linkedin.com\/in\/mbarrero\/\" target=\"_blank\">https:\/\/www.linkedin.com\/in\/mbarrero\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-66 elementor-top-column elementor-element elementor-element-17640048\" data-id=\"17640048\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3453d9e5 elementor-widget elementor-widget-jet-breadcrumbs\" data-id=\"3453d9e5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"jet-breadcrumbs.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-jet-breadcrumbs jet-blocks\">\n\t\t<div class=\"jet-breadcrumbs\">\n\t\t<div class=\"jet-breadcrumbs__content\">\n\t\t<div class=\"jet-breadcrumbs__wrap\"><div class=\"jet-breadcrumbs__item\"><a href=\"https:\/\/www.neuraxpharm.com\/be-fr\/\" class=\"jet-breadcrumbs__item-link is-home\" rel=\"home\" title=\"Neuraxpharm\">Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e5e84e8 elementor-widget elementor-widget-heading\" data-id=\"e5e84e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">MIGUEL BARRERO<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-614cff3 elementor-widget elementor-widget-text-editor\" data-id=\"614cff3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Miguel Barrero Dur\u00e1n est Head of Business Development &amp; Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle.<\/p><p>Il a plus de 22 ans d\u2019exp\u00e9rience dans l\u2019industrie pharmaceutique, \u00e0 diff\u00e9rents postes et dans diff\u00e9rentes entreprises. Il a commenc\u00e9 sa carri\u00e8re professionnelle en 2000 chez Almirall, puis a rejoint Merck Serono en 2005 et Esteve en 2008, o\u00f9 il a occup\u00e9 des postes \u00e0 responsabilit\u00e9 dans le d\u00e9veloppement pharmaceutique, ce qui lui a permis d\u2019acqu\u00e9rir une vaste exp\u00e9rience technique et scientifique.<\/p><p>Avant de rejoindre Neuraxpharm, il a occup\u00e9 plusieurs postes de responsabilit\u00e9 dans le domaine du d\u00e9veloppement commercial, notamment dans l\u2019octroi de licences chez Invent Farma et Hetero Europe, ainsi que dans l\u2019obtention de licences et le d\u00e9veloppement commercial par le biais de partenariats strat\u00e9giques et de d\u00e9veloppements d\u2019entreprise.<\/p><p>Il a obtenu une licence en pharmacie de l\u2019universit\u00e9 de Barcelone et un MBA de l\u2019institut d\u2019enseignement international ESADE.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bacc1a9 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bacc1a9\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;e7d9f21&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7080505\" data-id=\"7080505\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-53f8d38 elementor-widget elementor-widget-spacer\" data-id=\"53f8d38\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm MIGUEL BARRERO Miguel Barrero Dur\u00e1n est Head of Business Development &amp; Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle. Il a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-28348","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MIGUEL BARRERO - Neuraxpharm Belgique<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIGUEL BARRERO\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm MIGUEL BARRERO Miguel Barrero Dur\u00e1n est Head of Business Development &amp; Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle. Il a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Belgique\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-12T10:08:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture est.\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\",\"url\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\",\"name\":\"MIGUEL BARRERO - Neuraxpharm Belgique\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/be-fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg\",\"datePublished\":\"2023-03-31T07:59:55+00:00\",\"dateModified\":\"2023-05-12T10:08:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#breadcrumb\"},\"inLanguage\":\"fr-BE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-BE\",\"@id\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#primaryimage\",\"url\":\"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg\",\"contentUrl\":\"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u00c0 propos de nous\",\"item\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comit\u00e9 Ex\u00e9cutif\",\"item\":\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"MIGUEL BARRERO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/be-fr\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/be-fr\/\",\"name\":\"Neuraxpharm Belgique\",\"description\":\"Un leader europ\u00e9en pour les produits CNS\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/be-fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-BE\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MIGUEL BARRERO - Neuraxpharm Belgique","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero","og_locale":"fr_FR","og_type":"article","og_title":"MIGUEL BARRERO","og_description":"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm MIGUEL BARRERO Miguel Barrero Dur\u00e1n est Head of Business Development &amp; Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle. Il a [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero","og_site_name":"Neuraxpharm Belgique","article_modified_time":"2023-05-12T10:08:29+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture est.":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero","url":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero","name":"MIGUEL BARRERO - Neuraxpharm Belgique","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/be-fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg","datePublished":"2023-03-31T07:59:55+00:00","dateModified":"2023-05-12T10:08:29+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#breadcrumb"},"inLanguage":"fr-BE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero"]}]},{"@type":"ImageObject","inLanguage":"fr-BE","@id":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#primaryimage","url":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg","contentUrl":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u00c0 propos de nous","item":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous"},{"@type":"ListItem","position":2,"name":"Comit\u00e9 Ex\u00e9cutif","item":"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif"},{"@type":"ListItem","position":3,"name":"MIGUEL BARRERO"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/be-fr\/#website","url":"https:\/\/www.neuraxpharm.com\/be-fr\/","name":"Neuraxpharm Belgique","description":"Un leader europ\u00e9en pour les produits CNS","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/be-fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-BE"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/pages\/28348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/comments?post=28348"}],"version-history":[{"count":0,"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/pages\/28348\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/media?parent=28348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}